Denosumab in Current Users of Bisphosphonates for Glucocorticoid-induced Osteoporosis

Summary

The purpose of this study is to study the efficacy of denosumab, a new drug, in the treatment of osteoporosis in patients using bisphosphonates.

Timeline

Start

2011-12

Primary completion

2014-04

Completion

2014-06

Publications

• Mok CC, Ho LY, Ma KM. Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial. Bone. 2015 Jun;75:222-8. doi: 10.1016/j.bone.2015.03.002. Epub 2015 Mar 8.

Drugs

Indications